Where Primerica Stands With Analysts

Within the last quarter, Primerica (NYSE:PRI) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

Within the last quarter, Primerica (NYSE:PRI) has observed the following analyst ratings:

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 2 0 3 0 0
Last 30D 0 0 1 0 0
1M Ago 1 0 0 0 0
2M Ago 0 0 0 0 0
3M Ago 1 0 2 0 0

These 5 analysts have an average price target of $194.6 versus the current price of Primerica at $182.23, implying upside.

Below is a summary of how these 5 analysts rated Primerica over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

price target chart

This average price target has increased by 22.2% over the past month.

Stay up to date on Primerica analyst ratings.

Analyst Ratings: What Are They?

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Watching Catalent; Traders Circulating Possible Rumor Suggesting Gordon Haskett Saying Activist Could Be Pressing CTLT To Sell. Believes DHR “Still” Very Interested In Acquiring Catalent

Don't turn out the Catalent light just yet. The world may have been a little too quick to buy into the idea that Danaher (DHR) has lost interest in Catalent (CTLT). Bloomberg is responsible for that buy-in as it was the one to “report” on April 17 that DHR had stopped pursuing the CTLT. Strictly speaking, that may be the case as talks could have been shelved.

CTLT